Balyasny Asset Management’s PAVmed PAVM Stock Holding History

Balyasny Asset Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-30	Closed	-$12K	–	3162
2022 Q2	$12K	Buy	+30	New	+$14.5K	﹤0.01%	2560

Other funds holding PAVM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Balyasny Asset Management's PAVM Position: Q3 2022 in Review

Balyasny Asset Management sold out of PAVmed (PAVM) in Q3 2022, closing a stake of 30 shares — an estimated $12K sold.

Balyasny Asset Management first reported a position in PAVM in Q2 2022 and held it in 1 quarter. The position peaked at $12K in Q2 2022. 70 funds tracked by Wall St. Rank hold PAVM as of Q3 2022.

Balyasny Asset Management reported no remaining PAVmed position as of Q3 2022 after selling out during the quarter.
Balyasny Asset Management sold 30 PAVmed shares in Q3 2022, an estimated $12K.
Balyasny Asset Management first reported a position in PAVmed in Q2 2022 and held it in 1 quarter.
Balyasny Asset Management's PAVmed position peaked at $12K in Q2 2022.
70 funds tracked by Wall St. Rank held PAVmed as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.